Technology offer
The Germans Trias i Pujol Research Institute (IGTP) promotes the transfer of scientific knowledge to the healthcare system and the productive sector through the development of innovative solutions in diagnostics, therapy and medical technology. This technology portfolio brings together innovative projects from the Institute's research groups, classified by type and therapeutic area.
The Institute seeks to collaborate with companies, investors and institutions interested in licensing, co-developing or validating technologies with clinical and market potential. Through these partnerships, it aims to accelerate the translation of innovation to patients and contribute to a more effective, sustainable and evidence-based healthcare system.
| PROJECT | AREA | TYPE | PRINCIPAL INVESTIGATOR | OBJECTIVE | STAGE | PATENT | |
| ABEONA - Digitalising cancer recovery | Oncology | Medical Device | Andrea Plaja | Digital application for the prevention of chemotherapy-induced toxicity in colorectal cancer patients. The solution uses a SaaS and DaaS model to monitor patients in real time, detect early signs of toxicity and adapt treatment in a personalised way, improving safety and quality of life. | Proof of concept | ||
| ANALIFT - Device for the treatment of faecal incontinence | Community Health | Medical Device | Javier Corral | Connected medical device linked to a gamified mobile app that enables home-based biofeedback training to improve sphincter control and pelvic floor health. It facilitates rehabilitation outside the hospital and encourages treatment adherence. | Technological feasibility | ||
| Apotransferrin for stroke treatment | Neurology | Therapy | Teresa Gasull |
|
Preclinical validation | WO2013068504A1 | |
| BIOMARKIDS - Biomarkers for diagnosis and prognosis in hepatoblastoma patients | Oncology | IVD | Carolina Armengol | Clinical support tool based on molecular analysis and data algorithms to improve risk stratification in paediatric patients with hepatoblastoma. It optimises diagnostic classification and tailors treatment according to each patient's prognostic profile. | Technological feasibility | ||
| BLEBMAKER - First surgical implant for definitive glaucoma treatment | Ophthalmology | Medical Device | Jordi Loscos |
|
Technological feasibility | ||
| CHILD - New therapeutic approach for paediatric liver cancer | Oncology |
|
Carolina Armengol | Novel targeted therapeutic strategy for the treatment of paediatric hepatoblastoma. Based on an innovative translational medicine approach, the project aims to enhance treatment efficacy and reduce adverse effects in children. | Proof of concept | ||
| CS4P - Diagnostic biomarkers to predict mortality risk in shock patients | Cardiology | IVD | Antoni Bayés | In vitro diagnostic test based on a panel of four proteins that enables short-term mortality risk prediction in patients with cardiogenic shock, helping physicians optimise treatment and improve clinical prognosis. | Technological development | WO2020169751A1 | |
| DELIRIUM-IA - Artificial intelligence tool to predict, prevent and reduce acute confusional syndrome | Community Health | Medical Device | Isaac Nuño | Artificial intelligence tool designed to detect and prevent hospital delirium. It combines a predictive algorithm with an interactive device that stimulates and assesses the patient's cognitive state. | Proof of concept | ||
| Disinfectant against Legionella | Infectious Diseases | Biocide | Noemí Pàrraga | New generation of biocidal compounds that act effectively against Legionella in all its forms - planktonic, biofilm and intracellular - preventing recolonisation and ensuring safer, longer-lasting disinfection. | Proof of concept | ||
| DetectAR - Detection system for non-palpable breast cancer lesions | Oncology | Medical Device | Lidia Blay | DetectAR is a localisation system for non-palpable lesions in oncological surgery that uses augmented reality to display in real time the exact area to be resected, improving precision, reducing reoperations and costs, and optimising surgical workflow. | Technological feasibility | ||
| HEMOSHAKE - Medical device to enhance clearance during haemodialysis | Nephrology | Medical Device | Néstor Rodríguez | Technology that improves haemodialysis efficiency by applying controlled external energy to break the bond between toxins and blood proteins, facilitating their removal during treatment and improving survival and quality of life in patients with chronic kidney disease. | Proof of concept | ||
| INCARE 2.0 - Transforming ulcer care through objective decision support | Community Health | Medical Device | Marc Jante | Digital solution powered by artificial intelligence to detect and monitor complex wounds via mobile devices, improving early diagnosis and reducing complications and costs. | Proof of concept | ||
| LEWY-DX - In vitro method for the diagnosis of synucleinopathies | Neurology | IVD | Katrin Beyer | In vitro diagnostic test based on the analysis of platelet miRNA that accurately differentiates dementia with Lewy bodies from Alzheimer's disease, improving diagnosis, clinical management and personalised treatment. | Technological development | WO2016180726A1 | |
| NANORADIOMED - Controlled-release nanoparticles to prevent radiodermatitis | Oncology | Medical Device | Sandra Cabrera | Formulation based on nanoparticles for the controlled release of active ingredients that prevent radiodermatitis in women undergoing radiotherapy for breast cancer, improving skin tolerance and quality of life during treatment. | Technological feasibility | ||
| NF2 RESTORE - Gene repair therapy for neurofibromatosis type 2 | Oncology | Therapy | Elisabet Castellanos | RNA-based gene therapy for the treatment of schwannomatosis related to the NF2 gene. It uses modified RNA molecules to restore NF2 gene function or block the effects of pathogenic mutations. | Proof of concept | ||
| NEUROACTIVE - From natural compounds to new drug development for post-stroke recovery | Neurology | Therapy | Teresa Gasull | Innovative therapeutic platform focused on modulating neuronal activity to restore brain function in neurodegenerative diseases. It combines biotechnology and precision approaches to improve synaptic plasticity and functional recovery. | Technological feasibility | ||
| RADIOLUNG - Mapping lung tumours beyond medical imaging | Pneumology | Medical Device | Antoni Rosell |
|
Technological development | WO2024146849A1 | |
| RACEPLUS - Artificial intelligence application for prehospital stroke diagnosis and management | Neurology | Medical Device | Natàlia Pérez de la Ossa | Artificial intelligence-based application for the diagnosis and management of stroke in prehospital settings. It integrates clinical data and the RACE scale score to rapidly and accurately predict stroke type and identify large vessel occlusion (LVO) candidates for endovascular treatment. | Proof of concept | ||
| RESISTA - Development of new treatments for infections caused by multidrug-resistant Staphylococcus aureus | Infectious Diseases | Therapy | Noemí Párraga | New antimicrobial treatment for infections caused by multidrug-resistant Staphylococcus aureus (including MRSA), initially aimed at treating sepsis and skin infections, and later prosthetic joint infections. | Technological feasibility | ||
| RUSH-PoC - Rapid detection of ischaemic stroke in prehospital settings using a Point-of-Care test | Neurology | IVD | Núria de Gregorio | Rapid diagnostic test to distinguish between ischaemic and haemorrhagic stroke before hospital arrival, aiming to reduce treatment time and improve patient recovery. | Technological feasibility | ||
| RUTIGLOVES - High-safety surgical gloves | General Surgery | Medical Device | Joan Francesc Julian | New formulation for manufacturing surgical gloves with enhanced puncture resistance to improve protection and reduce infection risk among healthcare professionals. | Proof of concept | ||
| RUTIEBUS - Development of a new bronchoscopy system based on miniaturised probes | Pneumology | Medical Device | Felipe Andreo | Next-generation bronchoscopy system based on miniaturised probes that enables precise navigation through the airways. It facilitates safer diagnosis and treatment of pulmonary diseases. | Technological feasibility | ||
| RUTIPASTE - Prevention of anastomotic leaks with bioabsorbable sealing | General Surgery | Medical Device | Joan Francesc Julian | Bioabsorbable sealant designed to prevent post-surgical tissue leaks. It provides immediate adhesion in wet tissue and structural support, reducing complications and improving patient recovery. | Technological development | ||
| RUTISETON - Treatment of anal fistula in outpatient settings without general anaesthesia | Community Health | Medical Device | Jose Troya | New seton device with simplified closure and a flexible tip that allows use without surgery or general anaesthesia, reducing treatment time and patient discomfort. | Proof of concept | ||
| SNIPer - Combining the power of surgery and light in cancer treatment | Oncology | Medical Device | Ana Piqueras | Innovative medical device that enables image-guided surgical interventions and tumour cell elimination through light. Integrated into existing systems, it allows precise resection and localised cancer treatment in real time. | Proof of concept | ||
| TB-OMICS - Identification of metabolomic signatures in urine samples for tuberculosis diagnosis | Infectious Diseases | IVD | Jose Domínguez | Innovative diagnostic method based on the identification of metabolomic signatures in urine samples to detect tuberculosis rapidly, non-invasively and in resource-limited settings. | Technological development | WO2019243347A1 | |
| THYROMET - Modelling the future of thyroid cancer through epigenetics | Oncology | IVD | Mireia Jordà | In vitro test based on DNA methylation biomarkers that predicts metastasis risk in thyroid cancer patients. It supports treatment personalisation, prevents overtreatment and improves patient prognosis and quality of life. | Proof of concept | ||
| VESICLE-X - 3D matrix enriched with extracellular vesicles as an innovative therapy for Crohn's disease | Digestive Diseases | Therapy | Josep Manyé | Biomedical device based on extracellular vesicles designed to prevent postoperative recurrence in Crohn's disease patients. It offers a new biological therapeutic approach with local regenerative and anti-inflammatory capacity. | Proof of concept | ||